Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Evaluating medications in animal laboratory paradigms can reveal whether the compound is effective in an established alcoholism model, at clinically relevant doses and exposure conditions, when administered orally (or transdermally) and without serious limiting side effects. Positive outcomes constitute a possible discovery for relevance to alcoholism and, under favorable marketing conditions, encourage further development. Medication testing using animal models of alcoholism might also guide clinical testing by discriminating clinically effective from clinically ineffective compounds. This ability rests on whether there are tests or, more reasonably, batteries of tests having this discriminative ability. The present paper examines this possibility. Effects of naltrexone and acamprosate in animal paradigms which model behavioral aspects of alcoholism are reviewed and compared with the effects of compounds which have limited effects in alcoholics. It is not clear at present whether any single paradigm or combination of paradigms differentiates clinically effective from clinically limited compounds. Steps are suggested to improve the use of preclinical laboratory tests to predict which compounds are likely to be effective medications for reducing drinking and sustaining abstinence in human alcoholics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence for Addiction-like Behavior in the Rat
Deroche-Gamonet, V., Belin, D., & Piazza, P. V. (2004) · Science · doi:10.1126/science.1099020 · Cited by 1,135
Drug Seeking Becomes Compulsive After Prolonged Cocaine Self-Administration
Vanderschuren, L. J. M. J., & Everitt, B. J. (2004) · Science · doi:10.1126/science.1098975 · Cited by 733 · cited 2×
“Although existing alcohol drinking paradigms model aspects of addiction to ensure sufficient mechanistic diversity, it will also be important to adapt emerging paradigms which model the transition to addiction-like behavior (e.g. DerocheGamonet et al., 2004; Vanderschuren & Everitt, 2004).”
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618 · cited 1×
“Even medications such as naltrexone, which show clinical efficacy in the preponderance of double-blind, placebo-controlled trials, have failed to show efficacy in some studies (see Fuller & Gordis, 2001; Krystal et al., 2001).”
Decreases in dopamine receptors but not in dopamine transporters in alcoholics
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Hitzemann, R., Ding, Y., Pappas, N., Shea, C., & Piscani, K. (1996) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb05936.x · Cited by 612
The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption
Spanagel, R., Pendyala, G., Abarca, C., Zghoul, T., Sanchis-Segura, C., Magnone, M. C., Lascorz, J., Depner, M., Holzberg, D., Soyka, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1163 · Cited by 594 · cited 1×
“NPY (Thiele et al., 1998), ENT1 (Choi et al., 2004), Per2 (Spanagel et al., 2005), the adenosine A2A receptor (Naassila et al., 2002) and delta-opioid receptor (Roberts et al., 2001) are among the targeted gene mutations which elevate alcohol drinking.”
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444 · cited 2×
“Serotonin-specific reuptake inhibitors (SSRIs) have been tested sufficiently often to conclude that they are not therapeutically effective for non-depressed alcoholics (Garbutt et al., 1999; Torrens et al., 2005).”
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387 · cited 1×
“Thus, the CRF receptor antagonist d-Phe-CRF reduced ethanolreinforced level pressing only in rats with a history of ethanol dependence (Valdez et al., 2002).”
Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats
Roberts, A. J., Cole, M., & Koob, G. F. (1996) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01125.x · Cited by 340 · cited 1×
“NPY (Thiele et al., 1998), ENT1 (Choi et al., 2004), Per2 (Spanagel et al., 2005), the adenosine A2A receptor (Naassila et al., 2002) and delta-opioid receptor (Roberts et al., 2001) are among the targeted gene mutations which elevate alcohol drinking.”
Le Magnen, J., Tran, G., Durlach, J., & Martin, C. (1987) · Alcohol · doi:10.1016/0741-8329(87)90005-x · Cited by 97
Cited by
A key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
HEILIG, M., & EGLI, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.001 · Cited by 377
Self-citationSommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309
Ciccocioppo, R., Economidou, D., Cippitelli, A., Cucculelli, M., Ubaldi, M., Soverchia, L., Lourdusamy, A., & Massi, M. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00032.x · Cited by 166
“2000; Egli 2005).”
Bell, R. L., Lopez, M. F., Cui, C., Egli, M., Johnson, K. W., Franklin, K. M., & Becker, H. C. (2015) · Addiction Biology · doi:10.1111/adb.12106 · Cited by 138
Self-citation
Metadata
- Authors
- Egli, M.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2005-12
- Volume
- 10
- Issue
- 4
- Pages
- 309-319
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W2074613132
- Cited by
- 85
- References
- 9
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? https://app.cochat.ai/papers/10.1080/13556210500314550
- The paper
- Egli, M. (2005). Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? Addiction Biology. https://doi.org/10.1080/13556210500314550
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.